Development and validation of a highly specific in-house chemiluminescent-based serological assay for the detection of antibodies directed against the human monkeypox virus

J Virol Methods. 2023 Dec:322:114836. doi: 10.1016/j.jviromet.2023.114836. Epub 2023 Oct 27.

¹ Laboratoire de Santé Publique du Québec, Sainte-Anne-de-Bellevue, QC, Canada; Institut National de Santé Publique du Québec, Sainte-Anne-de-Bellevue, QC, Canada.
² Centre de Recherche du CHUM, Montréal, QC, Canada; Université de Montréal, Montréal, QC, Canada.
³ Clinique médicale l'Agora, Montréal, QC, Canada.
⁴ Centre de Recherche du CHUM, Montréal, QC, Canada.
⁵ Laboratoire de Santé Publique du Québec, Sainte-Anne-de-Bellevue, QC, Canada; Institut National de Santé Publique du Québec, Sainte-Anne-de-Bellevue, QC, Canada. Electronic address: judith.fafard@inspq.qc.ca.

No abstract available

Keywords: A29L; Antibodies; ELISA; HIV-1 co-infection; MPXV; Monkeypox; Mpox; Poxvirus; Serology; Vaccination.

MeSH terms